1 / 18

CHIRURGIA MAGGIORE

LINEE GUIDA E FLOW CHART OPERATIVA PER LA SOSPENSIONE “SICURA” DELLA TERAPIA ANTIAGGREGANTE IN PREPARAZIONE DELL’INTERVENTO. CHIRURGIA MAGGIORE. Risk of early surgery after stent implantation. Early surgery after stent implantation: High risk after discontinuation of dual antiplatelet therapy.

nailah
Download Presentation

CHIRURGIA MAGGIORE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. LINEE GUIDA E FLOW CHART OPERATIVA PER LA SOSPENSIONE “SICURA” DELLA TERAPIA ANTIAGGREGANTE IN PREPARAZIONE DELL’INTERVENTO CHIRURGIA MAGGIORE

  2. Risk of early surgery after stent implantation

  3. Early surgery after stent implantation: High risk after discontinuation of dual antiplatelet therapy

  4. LINEE GUIDA ESC 2009

  5. VALUTAZIONE RISCHIO/BENEFICIO ED IMPATTO CLINICO trombosi emorragia DES su TC/IVA Ultimo vaso Neurochirurgia Chirurgia Oftalmica

  6. Risk factors for stent thrombosis

  7. STRATIFICAZIONE PER RISCHI TROMBOSI/EMORRAGIA RISCHIO EMORRAGICO RISCHIO TROMBOTICO Adattata da Riddell et al, Circulation 2007; 116: e378-e382

  8. Protocollo Ospedale Niguarda

  9. Clopidogrel bridging protocol Inclusion criteria • Consecutive candidates for urgent major (CV or non-CV) surgery • or eye surgery in whom dual antiplatelet therapy could not be withdrawn as the time of surgery was within 6 months of the placement of any DES, or within one year of the placement of any DES under conditions considered to be at higher risk for stent thrombosis: • stent implantation due to an ACS, • diabetes, • renal insufficiency or • severe left ventricular dysfunction, • stents placed in LMCA, proximal LAD (or equivalent), bifurcation

  10. - 8 cardiac surgery, 6 urinary tract , 10 gastroenteric surgery, 5 other surgery- No MACE ( death, MI, stroke )- 1 TIMI major bleeding- 8 patients required blood transfusion (6 before surgery for anemia, 2 post-operatively for proctorrhagy ). Global experience : 30 patients

  11. Patient characteristics and bleedinggastroenteric surgery

  12. Patient characteristics and bleedingurinary tract surgery

  13. Patient characteristics and bleeding: Cardiac surgery

  14. LIMITAZIONI DEL PROTOCOLLO ‘NIGUARDA’ • Utilizzo ‘off label’ del tirofiban • Persiste rischio emorragico non trascurabile • Incertezze associazione eparina

More Related